Prevalence of problem alcohol use among patients attending primary care for methadone treatment by Ryder, Niamh et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Family Practice
Open Access Research article
Prevalence of problem alcohol use among patients attending 
primary care for methadone treatment
Niamh Ryder†1, Walter Cullen*†1, Joseph Barry2,3, Gerard Bury1, 
Eamon Keenan4 and Bobby P Smyth2,4
Address: 1UCD School of Medicine and Medical Science, Coombe Healthcare Centre, Dublin, Ireland, 2Department of Public Health and Primary 
Care, Trinity College, Dublin, Ireland, 3Department of Public Health, Health Services Executive, Dublin, Ireland and 4Addiction Services, Health 
Services Executive, Dublin, Ireland
Email: Niamh Ryder - niamh.ryder@ucd.ie; Walter Cullen* - walter.cullen@ucd.ie; Joseph Barry - joebarry@tcd.ie; 
Gerard Bury - gerard.bury@ucd.ie; Eamon Keenan - Eamon.keenan@hse.ie; Bobby P Smyth - bobby.smyth@hse.ie
* Corresponding author    †Equal contributors
Abstract
Background: Problem alcohol use is associated with adverse health outcomes among current or
former heroin users and primary care is providing methadone treatment for increasing numbers of
this population. This study aimed todetermine the prevalence of problem alcohol use among
current or former heroin users attending primary care for methadone treatment and to describe
the socio-demographic characteristics and health service utilisation characteristics associated with
problem alcohol uses.
Methods: We conducted a cross sectional survey of patients sampled from a national database of
patients attending general practice for methadone treatment. Participants were recruited by their
general practitioner and data was collected using an interviewer-administered questionnaire, which
included the Alcohol Use Disorders Identification Test ('AUDIT'), with a score of >7 considered
abnormal (ie 'AUDIT positive cases') and socio-demographic, medical and substance use
characteristics.
Results: We interviewed 196 patients (71% of those invited, 31% of those sampled, 11% of the
national database). The median age was 32 years, 55% were hepatitis C positive, 79% had used illicit
drugs in the previous month and 68% were male. Sixty-eight 'AUDIT positive' cases were identified
(prevalence of 35%, 95% CI = 28–41%) and these were more likely to have attended a local
Emergency Department in the previous year (p < 0.05) and less likely to have attended a hospital
clinic in the previous year (p < 0.05). Twenty-seven (14%) scored 20 or higher indicating possible
alcohol dependence.
Conclusion: Problem alcohol use has a high prevalence among current or former heroin users
attending primary care for methadone treatment and interventions that address this issue should
be explored as a priority. Interventions that address problem alcohol use in this population should
be considered as a priority, although the complex medical and psychological needs of this
population may make this challenging.
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Background
Problem alcohol use is associated with adverse health out-
comes and is a common problem among people who use
heroin and other illicit opiates, with one-third of opiate-
using patients attending a specialist addiction clinic in the
UK being identified as 'problem drinkers, hazardous
drinkers or alcohol dependent' on screening [1].
The adverse health implications of problem alcohol use
among patients on methadone treatment include:
Injecting drug users are at high risk of liver disease result-
ing from hepatitis C infection and in Ireland, 62–81% of
injecting drug users are hepatitis C positive [2]. Problem
alcohol use is an important factor in determining poor
prognosis among people with hepatitis C infection as life-
time consumption of alcohol and occasional heavy alco-
hol drinking have been shown to play an additive role in
determining progression to hepatic cirrhosis [3]. In addi-
tion, excessive alcohol intake is associated with increased
HCV-RNA levels and elevated hepatic aminotransferase
levels [4].
Problem alcohol use also affects addiction treatment, by
impacting negatively on treatment outcomes [5] and by
affecting methadone metabolism [6] and the dose of
methadone that must be prescribed [7]. Alcohol is an
important factor in fatal opiate overdose [8], especially if
a person has ingested other central nervous system depres-
sants [9].
In Ireland, addressing problem alcohol use has recently
been identified as a priority for population health. Since
1995, there has been a dramatic increase in alcohol
related harm in Ireland, with this harm observed across a
range of health and social indicators [10]. While no pub-
lished data has reported the prevalence of problem alco-
hol use among patients on methadone treatment, a
recently published qualitative survey of patients attending
primary care for methadone treatment has suggested
problem alcohol use may be a common problem, with
patients possibly even substituting opiate dependency
with alcohol dependence [11].
The role of primary care in addressing problem alcohol
use has been described. A review of brief, multi-contact
behavioural counselling interventions among adult
patients attending primary care found that such interven-
tions reduced the average of drinks per week by 13–34%
and increased the proportion drinking at moderate or safe
levels by 10%–19% and concluded that such interven-
tions were feasible and potentially highly effective com-
ponents of an overall public health approach to reducing
alcohol misuse [12].
As alcohol-related harm is such a key issue for population
health and as current or former drug users are at particular
risk of alcohol-related harm (and therefore benefit from
therapeutic interventions) further data regarding problem
alcohol use among this group are needed. With primary
care increasingly involved in providing addiction care and
with an increased evidence base regarding the role of pri-
mary care in addressing problem alcohol use, data regard-
ing problem alcohol use among current or former heroin
users attending primary care are needed. This paper is the
first to report on a problem alcohol use among patients
attending primary care for treatment.
The primary objective of this study therefore was to deter-
mine the prevalence of problem alcohol use among cur-
rent or former heroin users attending primary care for
methadone treatment. The secondary objective was to
identify the socio-demographic characteristics and health
service utilisation characteristics of those patients with
problem alcohol use.
Methods
Setting
Heroin use has been a longstanding problem issue in
Dublin city, where an estimated 16.0 per thousand of the
adult population currently use illicit opiates [13]. In Ire-
land, although the number of new cases presenting for
addiction treatment has increased in recent years (59.0
per hundred thousand of the adult population during
1998 to 69.1 per hundred thousand of the adult popula-
tion during 2002), the number of these new cases report-
ing opiate addiction has fallen (855 in 1998 to 729 in
2002) [14].
In Ireland, addiction treatment is currently provided by
specialist addiction treatment services, including a central
Drug Treatment Centre Board, regional addiction centres,
community-based projects (satellite clinics) and by pri-
mary care. The most recently published data at the time of
this study indicated that 7845 patients were treated for
problem drug use by these agencies in 2002, with opiates
the most common drug for which people attended for
treatment (86% of total) [14].
In recent years, the number of GPs who provide addiction
treatment in the form of methadone prescribing has
increased in Ireland, the UK and elsewhere in the EU [15-
19]. To prescribe methadone in Ireland, GPs must com-
plete specific training and are subject to clinical audit,BMC Family Practice 2009, 10:42 http://www.biomedcentral.com/1471-2296/10/42
Page 3 of 10
(page number not for citation purposes)
with GPs who provide methadone treatment for 15 or
more patients subject to more regular audit and advanced
training ('level 2' GPs) [20]. This system is analogous to
the 'GPs with a special interest' ('GPWsi') model currently
operating in the UK [21].
Initiation of methadone treatment is only permitted in
specialist addiction clinics or by 'level 2' GPs [20]. Opiate
users with complex histories or significant comorbid diffi-
culties are initially cared for in a specialist addiction clinic
and their care transferred to general practice when stable.
Subjects, power calculation and sampling
A national database of patients being prescribed metha-
done was used to identify potential subjects. Since the
introduction of legislation regulating the prescribing of
methadone in Ireland, it has not been possible to dis-
pense methadone to a patient unless his or her name is
entered on this database, which is held by the Drug Treat-
ment Centre Board (Central Methadone Treatment List).
Each patient's name is accompanied by the name of a cor-
responding prescribing doctor and dispensing pharmacy
[20].
At the time of the study, the national database indicated
2585 patients were attending primary care for methadone
treatment. We estimated that sampling 629 patients (25%
of all those on the database) would yield a 95% confi-
dence interval of +/- 4% around a prevalence estimate of
patients who meet the criteria for 'problem drinkers, haz-
ardous drinkers or alcohol dependent drinkers' of 33%.
This allowed for a non-response rate of 30%, which we
felt was a conservative estimate given the proposed study
methodology. As cases were sampled individually from
the national database, we did not control for the cluster-
ing effect in determining our sample size.
Study instrument
An interviewer-administered questionnaire containing
the primary study instrument, the Alcohol Use Disorders
Identification Test ('AUDIT') was used. The 'AUDIT' is a
10-item screening questionnaire, whose applicability in
detecting patients with alcohol problems in primary care
has been validated. It contains questions relating to fre-
quency of drinking, typical quantity, frequency of heavy
drinking, impaired control over drinking, increased sali-
ence of drinking, morning drinking, guilt after drinking,
blackouts, alcohol-related injuries and others concerned
about drinking [22].
Data collection
The interviews were conducted between February 2006
and October 2007. At the time of the study, addiction
treatment services in Ireland were organised in four geo-
graphical areas and data collection was staggered to allow
data be collected on a region by region basis.
A researcher with no input into clinical care administered
the questionnaire by interview, an approach allowing
clarification of ambiguous answers and administration of
the questionnaire to patients with poor literacy skills [22].
Additional self-reported data on a range of variables
which could be associated with problem alcohol use were
also recorded, including: socio-demographic and sub-
stance use characteristics, addiction care and other medi-
cal issues.
Data analysis
Data was analysed using Statistical Packages for the Social
Sciences (SPSS) version 12.0. Each question on the
'AUDIT' questionnaire has a standard set of responses
from which to chose, each scored from 0 to 4 and a total
score of 8 or above was considered abnormal (ie 'AUDIT
positive cases), with a score of 8–15 indicative of 'hazard-
ous' alcohol use, 16–19 indicative of 'harmful' alcohol use
and 20 or above indicative of possible alcohol depend-
ence [22].
Analytical techniques included Pearson's chi squared test
and Fisher's exact test statistic (used in the case of small
sample sizes) to determine the significance of associations
between categorical variables. Odds ratios and their 95%
confidence intervals (CI) were used to describe the rela-
tionship between subject characteristics and abnormal
scores on AUDIT questionnaire. Multivariate analyses
were performed using logistic regression, with variables
found to be significant on univariate testing entered into
the regression equation.
Ethical considerations
A step-wise approach to patient recruitment was used.
Patients attending primary care for methadone treatment
were randomly sampled from the Central Treatment List.
The GP of each potential participant was then invited to
participate in the study, asked to approach the named
patient to determine if s/he was willing to meet with the
researcher. Potential participants were provided with writ-
ten information regarding the study and if willing to par-
ticipate, an appointment to meet with a member of the
research team.
At this meeting, patients were provided with further expla-
nation on the study, the nature of the questions that
would be asked and they were encouraged to express any
concerns or issues requiring clarification. In particular, it
was made explicit to patients that non-participation in the
study would not compromise the care they receive. When
all such issues had been explained to the patient's satisfac-
tion, he or she was asked to consent to participate in the
study by signing a consent form.
Participation in the study by GPs and patients was on a
voluntary basis. No inducements to participate wereBMC Family Practice 2009, 10:42 http://www.biomedcentral.com/1471-2296/10/42
Page 4 of 10
(page number not for citation purposes)
offered and refusal to participate did not compromise
patient care.
While information from individual interviews was not
reported to the patient's GP, all patients were advised to
discuss the issue of problem alcohol use and any issues
that had been raised by the interview with their GP. It was
also made explicit that the interview with the researcher
was for research purposes and did not constitute any
aspect of their clinical care and merely represents part of a
research project. All data was anonymised and any details
that could potentially identify individuals were removed.
The study was approved by the Research Ethics Commit-
tee of the Irish College of General Practitioners
Results
Sample recruitment and socio-demographic 
characteristics
We randomly sampled 634/2585 patients (25% random
sample) from the national database, but 358 were not
invited to participate in the study because their GP
declined to participate in the study, did not respond to
two written invitations and five or more follow up tele-
phone contacts or because at the time of recruitment, they
were no longer attending the practice for methadone treat-
ment. Therefore, 276 patients were invited to participate
in the study (10.7% of those on national database), of
whom we interviewed 196 (71% participation rate among
those invited but 31% of random sample) (see Figure 1 –
patient recruitment).
Table 1 compares the characteristics of the sample
recruited for this study with most recent data on patients
attending general practice for methadone treatment and
patients attending for treatment of problem drug use in
Ireland [14,23,24]. The sample recruited for this study
had a median age of 32 years and 133(68% were male). A
total of 88(45%) indicated they were currently in full or
part time employment, 116(59%) reported they were in a
relationship and 77(39%) reported they were living with
their partner/spouse at the time of interview. One hun-
dred and forty (71%) reported they had children and 85
(43%) reported they were currently living with their chil-
dren. Thirty seven (19%) reported they lived in their own
home, 83(42%) lived in rented accommodation,
62(32%) lived in their parents'/other family member's
home and three (2%) reported they were homeless and 11
did not answer.
Problem alcohol and substance use
Of the 196 interviewed, 68 (35%) scored positive on the
AUDIT screening instrument, indicating hazardous,
harmful or dependent alcohol use. Of these 'AUDIT posi-
tive' cases, 33 scored 8–15 (indicative of 'hazardous' alco-
hol use), 8 scored 16–19 (indicative of 'harmful' alcohol
use) and 27 scored 20 or higher (indicative of possible
alcohol dependence).
All participants had a history of heroin use. The median
age of first heroin use was 18 years. A total of 149 (76%)
indicated they had ever injected drugs, with 19 years the
median age of first injecting drug use. All were being pre-
scribed methadone by their GP at the time of the interview
(median dose 75 mgs daily), with 48 months the median
length of time they had been attending that specific prac-
tice and 48 months also the median length of time they
had been prescribed methadone on this treatment epi-
sode. When asked 'which term best described' their 'type
of treatment', 36(18%) indicated they were on 'detoxifica-
tion' with the remainder indicating they were on 'mainte-
nance' treatment.
One hundred and fifty-five (79%) had used at least one
other illicit substance in the previous month, with
119(61%) using cannabis, 49(25%) using heroin,
22(11%) using illicit methadone, 42(21%) using illicit
benzodiazepines, 26(13%) using cocaine, 6(3%) using
crack cocaine and 3(2%) using amphetamines. Nine (5%)
participants reported injecting drug use, heroin in all
cases, in the month before interview.
Other medical issues
With regard to bloodborne virus infections, 188(96%)
claimed to know their hepatitis C status, 114(58%) had a
test in the previous 12 months and 107(55%) indicated
they were antibody positive. A total of 187(95%) claimed
to know their HIV status, 111(57%) had a test in the pre-
vious 12 months and 10(5%) indicated they were posi-
tive.
When asked to report contact with other health agencies
in the year before the interview 39(20%) reported they
had attended a hospital clinic, with hepatitis C (29
respondents), psychiatry (three respondents) and back
pain (two respondents) being the clinics most commonly
attended. Thirty-four respondents (17%) reported they
had attended a local hospital Emergency Department dur-
ing this time, with trauma and/or musculoskeletal injuries
(14 respondents), liver problems (three respondents) and
chest pain (two respondents) being the most commonly
cited reasons.
Factors associated with problem alcohol use
Table 2 presents data exploring potential associations
between problem alcohol use and patient characteristics,
including sociodemographic characteristics, problem sub-
stance use or other medical issues. On univariate analysis,
AUDIT positive cases were significantly more likely to
have attended a local Emergency Department in the lastBMC Family Practice 2009, 10:42 http://www.biomedcentral.com/1471-2296/10/42
Page 5 of 10
(page number not for citation purposes)
year, to have used illicit benzodiazepines in the last
month or to have used illicit amphetamines in the last
month. They were significantly less likely to consider
themselves on maintenance (instead of detoxification)
treatment with methadone and less likely to have
attended a scheduled hospital clinic appointment in the
last year.
On multivariate analysis, AUDIT positive cases were still
significantly more likely to have attended a local Emer-
Patient recruitment Figure 1
Patient recruitment.
National database of patients attending GPs for methadone treatment (n=2585)  
Total randomly sampled from national database (n=634)  
Patients not invited to participate because GP declined to 
participate (n=28) 
Patients not invited to participate because they were no longer 
attending practice at time of recruitment (n=13) 
Patients not invited to participate because GP did not respond 
(n=317)
Patients invited to participate in study (n=276) 
Patient agreed to participate but declined to meet researcher / 
attend for interview (n=11) 
Patient declined to participate (n=69) 
Patients interviewed (n=196) BMC Family Practice 2009, 10:42 http://www.biomedcentral.com/1471-2296/10/42
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gency Department in the last year (Wald statistic = 5.8; p
< 0.05) and less likely to have attended a hospital clinic in
the last year (Wald statistic = 4.3; p < 0.05). Among the
107 who reported they were hepatitis C positive, problem
alcohol users were significantly less likely to have
attended a specialist hepatology clinics, odds ratio (95%
CI) = 0.17 (0.05–0.58); chi2 = 10.9 (p < 0.005).
Discussion
Summary of main findings
This study is the first to present data on the prevalence of
problem alcohol use among opiate dependent patients
attending primary care for methadone treatment. We
observed a prevalence of 35%, which is equivalent to rates
reported among opiate dependent patients treated in spe-
cialist settings. We also observed high rates of illicit sub-
stance use, hepatitis C infection and health service
utilisation. Twenty-seven (14%) scored 20 or higher on
the AUDIT questionnaire, which is indicative of possible
alcohol dependence.
We found problem alcohol use to be associated with illicit
drug use, attendance at a local Emergency Department
and having not attended a specialist hospital clinic.
Strengths and limitations of the study
A number of methodological issues must be considered in
interpreting our findings. Our participation rate was lower
than had been anticipated and Figure 1 outlines the rea-
son for this. While ethical considerations determined the
initial approach to potential participants should be made
by their GP, this step had a major impact on recruitment.
Table 1: Characteristics of sample population compared to other samples of patients attending for methadone/addiction treatment in 
Ireland.
Variable This study Patients attending GPs for 
methadone treatment 
(Barry, Personal 
Communication, 2005)
Patients attending 
general practice for 
methadone treatment 
[23,24]
All patients attending 
for problem drug use 
treatment in Ireland 
[14]
Demographics % male 68% 68% 72% 71%
% employed 45% NA NA 25.8%
% homeless 2% NA NA 3%
Median age at time of 
study (range)
32(20–55) 32(18–62) 28* 25.8(17.2–40.7)
Median age of first 
heroin use (range)
18(13–52) NA NA NA
Median age of first 
injecting drug use
19(13–39) NA 19.4* 19(15–28)
Bloodborne virus 
infections
% (of those tested) 
who were known to 
be HCV positive
55 NA 73 NA
% (of those tested) 
who were known to 
be HIV positive
5N A 9 N A
Geographical 
location of practice 
by health region
East Coast Area 38(30%) 333(13%) NA NA
Northern Area 39(18%) 751(29%) NA NA
South West Area 115(45%) 1325(51%) NA NA
Rest of Ireland 4(11%) 197(8%) NA NA
NA: Data not available/not reported.
* indicates mean value as median not reported.BMC Family Practice 2009, 10:42 http://www.biomedcentral.com/1471-2296/10/42
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Table 2: Factors associated with scoring greater than 7 on AUDIT questionnaire.
Factor AUDIT positive cases (n = 68) AUDIT negative cases (n = 128) Odds ratio (95% CI) Chi 2 statistic
(p value)
Sociodemographic characteristics
Age under 33 38(56%) 71(56%) 1.02(0.56–1.84) 0.00(0.96)
Male gender 50(74%) 83(65%) 1.51(0.79–2.88) 1.54(0.22)
Attending GP for 48 months or less 36(53%) 55(52%) 1.06(0.59–1.91) 0.34(0.85)
Currently in full or part-time 
employment
29(46%) 59(48%) 0.91(0.50–1.68) 0.09(0.76)
Living in own home 11(18%) 26(21%) 0.78(0.36–1.71) 0.39(0.54)
Living with at least one relative 41(65%) 75(62%) 1.17(0.62–2.20) 0.82(0.66)
Living with a partner/spouse 27(66%) 50(67%) 0.96(0.43–2.16) 0.01(0.93)
Has children 39(62%) 90(74%) 0.58(0.30–1.11) 2.77(0.10)
Living with children 22(56%) 63(70%) 0.56(0.26–1.21) 2.24(0.14)
Problem substance use
Current methadone treatment episode 
48 months or less
38(56%) 67(52%) 1.15(0.64–2.08) 0.22(0.64)
Methadone dose of 60 mgs or less daily 25(37%) 35(27%) 1.55(0.83–2.89) 1.86(0.17)
Maintenance methadone treatment * 50(74%) 110(86%) 0.46(0.22–0.95) 4.56(0.03)
First used heroin at 18 years or younger 44(65%) 80(63%) 1.08(0.58–1.99) 0.06(0.81)
Have injected heroin ever 47(69%) 102(80%) 0.57(0.29–1.12) 2.72(0.10)
Other medical issues
Tested for hepatitis C in the previous 12 
months
41(60%) 73(57%) 1.14(0.63–2.08) 0.19(0.66)
Perceived to be hepatitis C positive 36(58%) 71(56%) 1.07(0.58–1.98) 0.05(0.82)
Tested for HIV in the previous 12 
months
40(59%) 71(56%) 1.15(0.63–2.08) 0.20(0.65)
Perceived to be HIV positive 3(5%) 7(6%) 0.86(0.21–3.44) 0.05(0.83)
Attended a hospital clinic in the last year* 7(10%) 32(25%) 0.34(0.14–0.83) 6.03(0.01)
Attended a local Emergency Department 
in the last year*
17(25%) 17(13%) 2.18(1.03–4.61) 4.25(0.04)
Use of illicit substances in the previous month
Any illicit substance 57(84%) 98(77%) 1.59(0.74–3.41) 1.42(0.23)BMC Family Practice 2009, 10:42 http://www.biomedcentral.com/1471-2296/10/42
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Therefore, the possibility of selection bias can not be dis-
counted, with 345(54% of possible total) not even being
approached to participate in the study because their GP
either declined to participate in the study or did not
respond to repeated contacts by the research team. In Ire-
land, this is the first time that potential participants were
prospectively recruited on the basis of random sampling
from a national database of methadone prescribing. Our
experience with recruitment for this study would therefore
support more targeted approaches to recruitment, with
practices/GPs who wish to participate in similar research
being identified before sampling, with sampling occur-
ring at the level of the individual practices. While this
would have implications for power calculations, with
these needing to take account of the clustering effect, it
would lead to a higher participation rate and a more effi-
cient use of resources.
While we have no data on the GPs who did not participate
in the study, we have compared patients who participated
in the study with all patients attending general practice for
methadone treatment at the time of the study and found
our study sample to be comparable in terms of age and
gender (Barry, Personal Communication, 2005, see Table
1). The sample was also comparable to most recent data
on patients attending general practice for methadone
treatment and patients attending for treatment of prob-
lem drug use in Ireland, in terms of: gender, age of first
injecting, proportion that were homeless (see Table 1).
However, the sample is older, has a higher proportion that
report being employed and a lower proportion reporting
they are HCV or HIV positive [14,23,24]. Table 1 also
indicates that while our sample is representative in respect
of two geographical regions, one region (East Coast area)
is over-represented and one is under-represented (North-
ern Area) (Barry, Personal Communication, 2005).
Notwithstanding these similarities, our sample represents
only 31% of those randomly sampled from the national
database. This sample may represent the more 'stable' end
of the spectrum, in which case the possibility for our find-
ings to underestimate the prevalence of problem alcohol
use can not be discounted.
As our data essentially reports point prevalence of prob-
lem alcohol use (using the AUDIT questionnaire) and its
correlates, it offers no perspective on the natural history of
problem alcohol use or its temporal relationship to prob-
lem drug use. In that respect, longitudinal studies which
explore the relationship between problem drug use and
problem alcohol use over time will help us understand
factors associated with individuals developing this high-
risk co-dependency. We also note the previously described
limitations of using the AUDIT questionnaire alone to
determine treatment options in predicting treatments out-
comes [25].
Comparison with existing literature
Screening and treating patients attending general practice
for problem alcohol use is important for many reasons,
including: the high prevalence of hepatitis C and risk of
advanced liver disease [2,3], its negative impact on addic-
tion treatment outcomes [5] and its role in fatal opiate
overdose [8]. Our observed prevalence of problem alco-
hol was comparable to what has been reported in more
high-risk populations, i.e. patients attending addiction
clinics [1] and hospital in-patients [26].
This is a cause for concern as according to methadone pre-
scribing regulations in Ireland, one might expect patients
attending primary care for methadone treatment to have
less severe addiction problems [27]. Work conducted else-
where supports this view, indicating patients attending
primary care for methadone treatment were more likely to
be employed and to have less severe addiction problems
than those attending specialist addiction clinics [28].
Our finding that problem alcohol use was not signifi-
cantly associated with age or duration in treatment disa-
greed with our earlier exploratory work which suggested
Cannabis 46(68%) 73(57%) 1.58(0.85–2.92) 2.10(0.15)
Heroin 21(31%) 28(22%) 1.60(0.82–3.10) 1.92(0.17)
Methadone 10(15%) 12(9%) 1.67(0.68–4.09) 1.27(0.26)
Benzodiazepines* 21(31%) 21(16%) 2.28(1.14–4.56) 5.53(0.02)
Cocaine 12(17.6%) 14(11%) 1.75(0.76–4.02) 1.74(0.19)
Crack cocaine 1(2%) 5(4%) 0.37(0.04–3.21) 0.89(0.35)
Amphetamines* 3 (4%) 0(0%) N/A 5.74(0.02)
* association at < 0.05 significance level;
** association at < 0.01 significance level.
Table 2: Factors associated with scoring greater than 7 on AUDIT questionnaire. (Continued)BMC Family Practice 2009, 10:42 http://www.biomedcentral.com/1471-2296/10/42
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patients may substitute opiate dependence with alcohol
dependence [11]. Instead, we found concurrent abuse of
other substances was more common among problem
alcohol users, with alcohol therefore forming part of a
'polysubstance misuse' pattern – a finding in keeping with
work elsewhere [29]. This highlights the importance of
problem alcohol use being addressed in conjunction with
possible use of and/or addictions to other substances.
Other medical issues were common among our sample,
with 55% reporting they were HCV positive, 5% reporting
they were HIV positive, 20% reporting they had attended
a hospital clinic and 17% reporting they had attended a
local hospital Emergency Department in the previous
year. This high prevalence of hepatitis C infection rein-
forces why addressing problem alcohol use among cur-
rent or former drug users is so important.
The high contact rate with local hospital Emergency
Departments supports recently published data which
highlights problem alcohol use and problem substance
use as important factors in Emergency Department utilisa-
tion [10,30]. Among our sample, this Emergency Depart-
ment utilisation could be explained by their greater
involvement in high risk behaviours.
We observed a high contact rate with out patient second-
ary care among our sample and this would indicate
patients attending primary care for methadone treatment
have complex medical needs that need to be addressed in
addition to their primary addiction issues. We also found
that people with problem alcohol use were less likely to
engage with secondary care than people who did not
report problem alcohol use. Specifically, they were less
likely to have attended a specialist hospital clinic and, if
hepatitis C positive, were less likely to have attended spe-
cialist hepatology clinics.
Implications for future research and clinical practice
Many therapeutic interventions to address problem alco-
hol use have been described and evidence supports the
role of screening, further assessment, brief interventions,
more intensive treatments and alcohol-focussed specialist
treatment [31,32] and the role of primary care based 'brief
interventions' [33]. However, it is difficult to see whether
this evidence would translate to the care of problem alco-
hol use among patients attending general practice.
Although screening and treating for problem alcohol has
been identified as a potentially important element of
methadone treatment programmes [34], especially for the
most vulnerable clients [35], to date the implementation
of no such intervention in primary care has been
described. Our findings suggest that patients attending
primary care for methadone treatment should be screened
for problem alcohol use and should have access to care
interventions that address coexisting problem alcohol
use. With 14% of our sample reporting possible alcohol
dependence, access to more specialised interventions,
through integration with secondary care, would also
appear important.
However, this study indicates that complex medical and
psychological problems often coexist among this popula-
tion and may pose additional challenges in delivering evi-
dence based interventions that address problem alcohol
use. In that regard, further research to determine existing
care practices and to identify barriers to screening and
treatment for problem alcohol use among patients on
methadone treatment in primary care will be necessary to
inform future service delivery.
Conclusion
This study is the first to present data on the prevalence of
problem alcohol use among opiate dependent patients
attending primary care for methadone treatment and doc-
uments a high prevalence among this population. Inter-
ventions that address problem alcohol use in this
population should therefore be considered as a priority,
although the complex medical and psychological needs of
this population may make implementing such interven-
tions a challenge.
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